These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23329541)

  • 1. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems.
    Pal SN; Duncombe C; Falzon D; Olsson S
    Drug Saf; 2013 Feb; 36(2):75-81. PubMed ID: 23329541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa.
    Jones J; Swart A; Tommy E; Cohen K; Stewart A; Voget J; Blockman M
    S Afr Med J; 2020 Nov; 110(12):1226-1230. PubMed ID: 33403970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study.
    Avong YK; Jatau B; Gurumnaan R; Danat N; Okuma J; Usman I; Mordi D; Ukpabi B; Kayode GA; Dutt S; El-Tayeb O; Afolabi B; Ambrose I; Agbaji O; Osakwe A; Ibrahim A; Ogar C; Nosiri H; Avong EB; Adekanmbi V; Uthman O; Abimiku A; Oni YO; Mensah CO; Dakum P; Mberu KE; Ogundahunsi OAT
    PLoS One; 2018; 13(8):e0200810. PubMed ID: 30133453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.
    Herdeiro MT; Ribeiro-Vaz I; Ferreira M; Polónia J; Falcão A; Figueiras A
    Drug Saf; 2012 Aug; 35(8):655-65. PubMed ID: 22788235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
    Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
    Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canada's Adverse Drug Reaction Reporting System: A Failing Grade.
    Rawson NS
    J Popul Ther Clin Pharmacol; 2015; 22(2):e167-72. PubMed ID: 26590356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse event reporting tools and regulatory measures in India through outcome of Pharmacovigilance Programme of India.
    Prakash J; Sachdeva R; Shrivastava TP; Jayachandran CV; Sahu A
    Indian J Pharmacol; 2021; 53(2):143-152. PubMed ID: 34100398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance in India: Present Scenario and Future Challenges.
    Kalaiselvan V; Srivastava S; Singh A; Gupta SK
    Drug Saf; 2019 Mar; 42(3):339-346. PubMed ID: 30269244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
    Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
    Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
    Mulchandani R; Kakkar AK
    Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
    Adenuga BA; Kibuule D; Rennie TW
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monitoring medicines project: a multinational pharmacovigilance and public health project.
    Pal SN; Olsson S; Brown EG
    Drug Saf; 2015 Apr; 38(4):319-28. PubMed ID: 25829215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of patient reporting to the pharmacovigilance system: a systematic review.
    Inácio P; Cavaco A; Airaksinen M
    Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous adverse drug reaction reporting in rural districts of Mozambique.
    Sevene E; Mariano A; Mehta U; Machai M; Dodoo A; Vilardell D; Patel S; Barnes K; Carné X
    Drug Saf; 2008; 31(10):867-76. PubMed ID: 18759510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in Uganda.
    Ndagije H; Nambasa V; Namagala E; Nassali H; Kajungu D; Sematiko G; Olsson S; Pal S
    Drug Saf; 2015 Apr; 38(4):395-408. PubMed ID: 25749663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.